Breaking News

Siemens Agrees to Buy Dresser-Rand For $7.6 Billion in All Cash Deal
Tweet TWEET

Fresenius Medical Care Expands Treatment Options With Overnight Dialysis

  Fresenius Medical Care Expands Treatment Options With Overnight Dialysis

Convenience and Health Benefits Lead More Patients to Select Nighttime Therapy

Business Wire

WALTHAM, Mass. -- December 20, 2012

While daytime dialysis treatments are a fact of life for many thousands of
people with kidney failure, a growing number of dialysis patients are
discovering that dialyzing overnight lets them keep their days free for work,
family or other activities.

Nighttime dialysis is an increasingly popular option that allows patients to
receive treatments over ...

Nighttime dialysis is an increasingly popular option that allows patients to
receive treatments overnight, while sleeping or resting. Fresenius Medical
Care North America's nighttime dialysis option offers the same level of
supervised care as traditional daytime in-center treatments, except that
patients receive their dialysis at night, usually over a longer period of
time. (Photo: Business Wire)

Fresenius Medical Care North America (FMCNA), the nation’s leading network of
dialysis facilities, has established more than 140 in-center nocturnal, or
nighttime, dialysis programs across the country, including recently opened
programs in Weymouth, Mass.; Waco, Texas; Coeur d’Alene, Idaho; and Santa Fe,
Calif. More are scheduled to open in 2013.

Dialysis is a life-sustaining process that cleans waste products from the
blood and removes extra fluids when a person’s kidneys fail. Nighttime
dialysis is an increasingly popular option that allows patients to receive
treatments overnight, while sleeping or resting. FMCNA’s nighttime dialysis
option offers the same level of supervised care as traditional daytime
in-center treatments, except that patients receive their dialysis at night,
usually over a longer period of time.

Most patients on traditional daytime in-center dialysis receive treatments
three times a week for three to four hours at a time. In nighttime dialysis,
patients typically receive treatments three times a week, but for about eight
hours at a time. When dialysis is provided over a longer period, fluids are
removed more slowly, which results in a more gentle treatment for most
patients. Studies also suggest that nighttime dialysis patients may be able to
better control their blood pressure and mineral levels, resulting in fewer
dietary restrictions, which allows them to eat a wider variety of foods.

“In-center nocturnal dialysis is a viable alternative to standard in-center
dialysis for patients who require greater fluid and phosphorus removal and who
are amenable to spending three nights a week in the dialysis facility,” said
Dr. Eduardo Lacson, Jr., FMCNA’s vice president for clinical science,
epidemiology and research. Dr. Lacson recently published a study that
demonstrated health benefits, including improved clearance of phosphorus and
fluid, in nearly 750 FMCNA patients who switched from daytime to nocturnal
dialysis.

Hilton Mitchell, a 72-year-old dialysis patient in Kittery, Maine, has been
pleased with his results since switching from daytime to overnight dialysis
about a year ago. “Nighttime dialysis has changed my life, because I feel
better and have more energy,” he said. “It gives me more energy overall to
fish, hunt and travel.”

For more information about nighttime dialysis, please call toll-free at
1-866-4-DIALYSIS (1-866-434-2597) or visit
http://www.ultracare-dialysis.com/Treatment/InCenterDialysis/OvernightDialysis.aspx.

About Fresenius Medical Care North America

Through our leading network of more than 2,100 dialysis facilities in North
America and our vascular access centers, laboratory, pharmacy and affiliated
hospitals and nephrology practices, Fresenius Medical Care provides renal
services to hundreds of thousands of people throughout the United States,
Mexico and Canada. We are also the continent’s top producer of dialysis
equipment, dialyzers and related disposable products and a major supplier of
renal pharmaceuticals.

For more information about the company, visit www.fmcna.com; for information
about patient services, visit www.ultracare-dialysis.com.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20121220005088/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50513733&lang=en

Contact:

Media contact:
Loomis Group
Jaclyn Petros, 617-638-0022 / voice
petrosj@loomisgroup.com
or
Company contact:
Fresenius Medical Care
Rosemary Heinold, 781-699-4171 / voice
rosemary.heinold@fmc-na.com
 
Press spacebar to pause and continue. Press esc to stop.